$1.93
-0.03-1.59%
At close: -
$1.91
-0.02-0.84%
After Hours: Dec 20, 9:28 AM EDT
Comments
Loading...
Intensity Therapeutics (INTS) Forecast
NewsEarningsIntensity Therapeutics (INTS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestIntensity Therapeutics (NASDAQ:INTS) Stock Quotes, Forecast and News Summary
Intensity Therapeutics Stock (NASDAQ: INTS) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Intensity Therapeutics (INTS) stock?
You can purchase shares of Intensity Therapeutics (NASDAQ:INTS) through any online brokerage.
Who are Intensity Therapeutics (INTS) competitors?
Other companies in Intensity Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX), Curis (NASDAQ:CRIS) and Palatin Techs (AMEX:PTN).
What is the forecast, or price target, for Intensity Therapeutics (INTS) stock?
Intensity Therapeutics has a consensus price target of $8.50.
What is the current price for Intensity Therapeutics (INTS)?
The stock price for Intensity Therapeutics (NASDAQ: INTS) is $1.91 last updated December 20, 2024 at 9:28 AM EST.
Does Intensity Therapeutics (INTS) pay a dividend?
There are no upcoming dividends for Intensity Therapeutics.
When is Intensity Therapeutics (NASDAQ:INTS) reporting earnings?
Intensity Therapeutics’s Q4 earnings are confirmed for Thursday, March 13, 2025.
Is Intensity Therapeutics (INTS) going to split?
There is no upcoming split for Intensity Therapeutics.
What sector and industry does Intensity Therapeutics (INTS) operate in?
Intensity Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.